Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-11-20
1989-10-03
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549389, 514913, A61K 3135, C07D31192
Patent
active
048717649
ABSTRACT:
Novel 12-halogenated forskolin derivatives, intermediates and processes for their preparation, and methods for reducing intraocular pressure utilizing the compounds or compositions are disclosed.
REFERENCES:
patent: 4134986 (1979-01-01), Bajwa et al.
patent: 4476140 (1984-10-01), Sears et al.
patent: 4517200 (1985-05-01), Kreutner et al.
patent: 4639443 (1987-01-01), Kosley, Jr. et al.
patent: 4639446 (1987-01-01), Kosley, Jr. et al.
patent: 4677103 (1987-06-01), Kosley, Jr. et al.
Caprioli et al., "Forskolio Lowers Intraocular Pressure by Reducing Aqueous Inflow" in Invest. Ophthalmol. Vis. Sci., 25, 268, (1984).
Catchpole Wendy
Hoechst-Roussel Pharmaceuticals Inc.
Ikeda Tatsuya
Rollins John W.
LandOfFree
12-Halogenated forskolin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 12-Halogenated forskolin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 12-Halogenated forskolin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-664699